Spotlight On High Growth Tech Stocks In The US March 2025

Simply Wall St.
31 Mar

Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 5.8% over the past year with earnings forecasted to grow by 14% annually. In this context, identifying high growth tech stocks requires looking for companies that not only show robust revenue potential but also demonstrate resilience and adaptability in fluctuating market conditions.

Top 10 High Growth Tech Companies In The United States

Name Revenue Growth Earnings Growth Growth Rating
Super Micro Computer 20.44% 29.79% ★★★★★★
TG Therapeutics 26.18% 37.61% ★★★★★★
Alkami Technology 20.46% 85.16% ★★★★★★
Travere Therapeutics 28.43% 65.01% ★★★★★★
Clene 60.86% 63.07% ★★★★★★
Alnylam Pharmaceuticals 22.76% 58.56% ★★★★★★
AVITA Medical 27.91% 55.77% ★★★★★★
TKO Group Holdings 22.48% 25.17% ★★★★★★
Lumentum Holdings 21.55% 119.67% ★★★★★★
Ascendis Pharma 32.36% 59.79% ★★★★★★

Click here to see the full list of 234 stocks from our US High Growth Tech and AI Stocks screener.

Let's review some notable picks from our screened stocks.

Golden Matrix Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Golden Matrix Group, Inc. is a gaming technology company providing B2B and B2C solutions across Central and South America, Europe, and Africa, with a market cap of $269.46 million.

Operations: Golden Matrix Group generates revenue through its three main segments: Gmag ($12.48 million), Rkings & Cfac ($32.40 million), and Meridianbet Group ($106.23 million). The company's operations span across Central and South America, Europe, and Africa, focusing on both B2B and B2C gaming technology solutions.

Golden Matrix Group has demonstrated a robust expansion with a 62.5% revenue increase over the past year, significantly outpacing the industry average. Despite facing a net loss this year, as detailed in their latest earnings report, the company's strategic maneuvers—including appointing Richard Christensen as CFO and securing an online betting license in Brazil—position it for potential recovery and growth. These efforts underscore its commitment to innovation and market expansion, critical in the volatile tech landscape where adaptability is key to sustainability.

  • Dive into the specifics of Golden Matrix Group here with our thorough health report.
  • Examine Golden Matrix Group's past performance report to understand how it has performed in the past.

NasdaqCM:GMGI Revenue and Expenses Breakdown as at Mar 2025

Zai Lab

Simply Wall St Growth Rating: ★★★★★☆

Overview: Zai Lab Limited is a biopharmaceutical company focused on developing and commercializing innovative therapies for oncology, immunology, neuroscience, and infectious diseases, with a market cap of $4.07 billion.

Operations: Zai Lab Limited generates revenue primarily from its biotechnology segment, amounting to $398.99 million. The company focuses on developing and commercializing treatments across oncology, immunology, neuroscience, and infectious diseases.

Zai Lab's strategic focus on innovative cancer treatments is underscored by its recent progress with TIVDAK, which has shown promising results in reducing the risk of death by 45% in a specific patient cohort in China. This aligns with their significant R&D commitment, as evidenced by the increase in annual revenue to $398.99 million from $266.72 million, alongside a reduction in net loss from $334.62 million to $257.1 million year-over-year. Looking ahead, Zai Lab anticipates a revenue boost to between $560 million and $590 million for 2025, reflecting both the potential market impact of their oncology portfolio and ongoing innovation efforts within this high-stakes sector.

  • Delve into the full analysis health report here for a deeper understanding of Zai Lab.
  • Gain insights into Zai Lab's historical performance by reviewing our past performance report.

NasdaqGM:ZLAB Revenue and Expenses Breakdown as at Mar 2025

TaskUs

Simply Wall St Growth Rating: ★★★★☆☆

Overview: TaskUs, Inc. offers outsourced digital services across the Philippines, the United States, India, and other international markets with a market cap of approximately $1.23 billion.

Operations: The company's primary revenue stream is direct marketing, generating $994.99 million.

TaskUs, a player in the burgeoning field of AI-driven business process outsourcing, has demonstrated robust financial and operational growth. In 2024, the company's revenue is forecasted to grow by 10.5% annually, outpacing the US market average of 8.3%. This growth is supported by its strategic expansion into Agentic AI Consulting, which leverages advanced AI to enhance customer support and business processes. The initiative not only taps into TaskUs's deep industry expertise but also aligns with current technological trends towards automation and efficiency in workflows. Moreover, TaskUs reported a net income increase to $45.87 million for the full year ended December 31, 2024, up slightly from $45.69 million the previous year, reflecting its ongoing profitability despite ambitious expansions.

  • Click here to discover the nuances of TaskUs with our detailed analytical health report.
  • Explore historical data to track TaskUs' performance over time in our Past section.

NasdaqGS:TASK Earnings and Revenue Growth as at Mar 2025

Turning Ideas Into Actions

  • Click here to access our complete index of 234 US High Growth Tech and AI Stocks.
  • Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
  • Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Searching for a Fresh Perspective?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqCM:GMGI NasdaqGM:ZLAB and NasdaqGS:TASK.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10